Unigene Laboratories leads the industry in designing, delivering, manufacturing, and developing peptide-based therapeutics. In the expanding drug class based on the company’s Peptelligence platform, Unigene Laboratories is building a healthy portfolio of proprietary partnerships. Core assets of Peptelligence include proprietary oral and nasal peptide delivery technologies, as well as proprietary, high-yield, scalable and reproducible E. coli-based manufacturing technologies. For more information, visit the company’s Web site at www.unigene.com
ROTH Capital Partners is a relationship-driven investment bank that primarily focuses on connecting small-cap publicly traded companies with institutional investors. This year’s annual ROTH conference will take place at The Ritz Carlton located in Dana Point, CA, on March 11-14. Bringing together executives from more than 400 growth companies, the 24th Annual ROTH Conference is one of the largest of its kind in the U.S. For more information on ROTH Capital Partners, visit www.roth.com
Let us hear your thoughts below: